Despite advances in the primary treatment of non-Hodgkin's lymphoma, relapse is common and treatment after relapse is unsatisfactory. Autologous bone marrow transplantation, although sometimes successful, has generally had disappointing results. We conducted a trial of such transplantation in patients with relapsed non-Hodgkin's lymphoma, using strict criteria in selecting patients; we included only those in whom disease was minimal after conventional treatment (nodal disease less than 2 cm and bone marrow involvement less than or equal to 5 percent on histologic examination) and whose tumor cells expressed the B1 antigen. Forty-nine patients meeting these criteria received cyclophosphamide and whole-body irradiation supported by transplantation of autologous bone marrow that had been treated in vitro with anti-B1 monoclonal antibody and complement. All patients had features of a poor prognosis, including relapse from primary chemotherapy, histologic conversion to more aggressive disease, and extra-nodal dissemination. Thirty-three patients had a history of bone marrow involvement--16 at the time that marrow was obtained. Hematologic and immunologic engraftment was achieved in all patients. Only two treatment-related deaths occurred, from venoocclusive disease of the liver and intracerebral hemorrhage, respectively. Disease-free remission without maintenance therapy has lasted from greater than 2 to greater than 52 months in 34 patients (median follow-up, greater than 11 months). These results are similar to those obtained in patients with advanced, high-grade non-Hodgkin's lymphoma treated with primary combination chemotherapy. This study demonstrates that autologous bone marrow transplantation has tolerable toxicity and high efficacy in a subset of patients who are otherwise incurable but still responsive to cytoreductive therapy. The results suggest a role for such transplantation in the treatment of selected patients with newly diagnosed non-Hodgkin's lymphoma.
This article has been cited by other articles:
Hoppe, B. S., Moskowitz, C. H., Filippa, D. A., Moskowitz, C. S., Kewalramani, T., Zelenetz, A. D., Yahalom, J.
(2008). Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity. JCO
26: 1858-1864
[Abstract][Full Text]
Gopal, A. K., Rajendran, J. G., Gooley, T. A., Pagel, J. M., Fisher, D. R., Petersdorf, S. H., Maloney, D. G., Eary, J. F., Appelbaum, F. R., Press, O. W.
(2007). High-Dose [131I]Tositumomab (anti-CD20) Radioimmunotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Adults >= 60 Years Old With Relapsed or Refractory B-Cell Lymphoma. JCO
25: 1396-1402
[Abstract][Full Text]
Bellemare-Pelletier, A., Tremblay, J., Beaulieu, S., Boulassel, M.-R., Routy, J.-P., Massie, B., Lapointe, R., Thibodeau, J.
(2005). HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. J. Leukoc. Biol.
78: 95-105
[Abstract][Full Text]
Corradini, P., Ladetto, M., Zallio, F., Astolfi, M., Rizzo, E., Sametti, S., Cuttica, A., Rosato, R., Farina, L., Boccadoro, M., Benedetti, F., Pileri, A., Tarella, C.
(2004). Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes. JCO
22: 1460-1468
[Abstract][Full Text]
Ladetto, M., Corradini, P., Vallet, S., Benedetti, F., Vitolo, U., Martelli, M., Brugiatelli, M., Coser, P., Perrotti, A., Majolino, I., Fioritoni, G., Morandi, S., Musso, M., Zambello, R., Chisesi, T., Di Renzo, N., Vivaldi, P., De Crescenzo, A., Gallamini, A., Salvi, F., Santini, G., Boccomini, C., Sorio, M., Astolfi, M., Drandi, D., Pileri, A., Tarella, C.
(2002). High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood
100: 1559-1565
[Abstract][Full Text]
Williams, C. D., Harrison, C. N., Lister, T. A., Norton, A. J., Blystad, A. K., Coiffier, B., Taghipour, G., Schmitz, N., Goldstone, A. H.
(2001). High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin's Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry. JCO
19: 727-735
[Abstract][Full Text]
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., Long, G. D., Brown, B. W., Blume, K. G.
(2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood
97: 404-409
[Abstract][Full Text]
Friedberg, J. W., Neuberg, D., Stone, R. M., Alyea, E., Jallow, H., LaCasce, A., Mauch, P. M., Gribben, J. G., Ritz, J., Nadler, L. M., Soiffer, R. J., Freedman, A. S.
(1999). Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma. JCO
17: 3128-3135
[Abstract][Full Text]
Aristei, C., Tabilio, A.
(1999). Total-Body Irradiation in the Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoproliferative Diseases. The Oncologist
4: 386-397
[Abstract][Full Text]
Grossbard, M. L., Multani, P. S., Freedman, A. S., O'Day, S., Gribben, J. G., Rhuda, C., Neuberg, D., Nadler, L. M.
(1999). A Phase II Study of Adjuvant Therapy with Anti-B4-blocked Ricin after Autologous Bone Marrow Transplantation for Patients with Relapsed B-Cell Non-Hodgkin's Lymphoma. Clin. Cancer Res.
5: 2392-2398
[Abstract][Full Text]
Ladenstein, R., Pearce, R., Hartmann, O., Patte, C., Goldstone, T., Philip, T.
(1997). High-Dose Chemotherapy With Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry. Blood
90: 2921-2930
[Abstract][Full Text]
Paulus, U., Dreger, P., Viehmann, K., Neuhoff, N. v., Schmitz, N.
(1997). Purging Peripheral Blood Progenitor Cell Grafts from Lymphoma Cells: Quantitative Comparison of Immunomagnetic CD34+ Selection Systems. Stem Cells
15: 297-304
[Abstract][Full Text]
Hess, A. D., Bright, E. C., Thoburn, C., Vogelsang, G. B., Jones, R. J., Kennedy, M. J.
(1997). Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide. Blood
89: 2203-2209
[Abstract][Full Text]
Corradini, P., Astolfi, M., Cherasco, C., Ladetto, M., Voena, C., Caracciolo, D., Pileri, A., Tarella, C.
(1997). Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting. Blood
89: 724-491
[Abstract][Full Text]
Verdonck, L. F., van Putten, W. L.J., Hagenbeek, A., Schouten, H. C., Sonneveld, P., van Imhoff, G. W., Kluin-Nelemans, H. C., Raemaekers, J. M.M., van Oers, R. H.J., Haak, H. L., Schots, R., Dekker, A. W., de Gast, G. C., Lowenberg, B.
(1995). Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma. NEJM
332: 1045-1051
[Abstract][Full Text]
Cannistra, S. A.
(1993). Cancer of the Ovary. NEJM
329: 1550-1559
[Full Text]
Previous
